Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Akari Therapeutics ( (AKTX) ) just unveiled an update.
Akari Therapeutics announced a leadership change, with the termination of Wendy DiCicco’s role as Interim Chief Financial Officer. Samir Patel, the Interim CEO, has been appointed as Interim Principal Financial Officer and Principal Accounting Officer while the search for a permanent CFO is underway.
More about Akari Therapeutics
YTD Price Performance: -68.59%
Average Trading Volume: 37,647
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $11.9M
See more data about AKTX stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue